|
시장보고서
상품코드
2051377
혈당 모니터링 시장 : 유형별, 구성요소별, 최종사용자별, 지역별Blood Glucose Monitoring Market, By Type, By Component, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
혈당 모니터링 시장은 2026년에 230억 2,000만 달러로 추정되며, 2033년까지 465억 9,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 10.6%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 2,320억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 10.60% | 2033년 시장 규모 예측 : | 465억 9,000만 달러 |
혈당 모니터링은 환자가 정기적으로 혈당 수치를 확인하고 적절한 조치를 취할 수 있기 때문에 당뇨병 관리에 있어 매우 중요합니다. 자가 측정 기기의 접근성과 저렴한 가격, 그리고 당뇨병 관리에 대한 인식이 높아지면서 전 세계적으로 혈당 모니터링 솔루션의 보급이 확대되고 있습니다. 또한, 정확성, 편의성, 연결성을 향상시킨 혁신적인 모니터링 기기의 개발로 이어지는 기술 발전으로 인해 향후 몇 년 동안 시장 성장이 더욱 가속화될 것으로 예측됩니다.
시장 역학
세계 혈당 모니터링 시장은 전 세계 당뇨병 환자 수 증가와 당뇨병 관리에 대한 관심 증가를 배경으로 꾸준히 성장하고 있습니다. 비만 유병률 증가, 좌식 생활습관 등 다양한 요인들이 전 세계적으로 당뇨병의 부담을 증가시키고 있으며, 이는 혈당 측정기기의 보급을 촉진하고 있습니다. 또한, 선진국의 사용자 친화적이고 저렴한 측정 솔루션의 개발과 유리한 보험 환급 정책은 자가 측정 기기의 보급을 촉진하고 있습니다. 그러나 특히 개발도상국에서는 고급 혈당 측정기에 따른 고비용이 여전히 주요한 문제점으로 지적되고 있습니다. 또한, 사이버 위협 및 데이터 유출에 대한 취약성은 커넥티드 측정기기로의 전환을 방해할 수 있습니다. 그럼에도 불구하고 저침습적 지속적 혈당 측정 시스템 개발을 포함한 지속적인 기술 업그레이드는 시장 관계자들에게 밝은 전망을 가져다주고 있습니다.
본 조사의 주요 특징
- 이 조사에서는 각 부문의 잠재적 수익 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계 혈당 모니터링 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 모델 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 세계 혈당 모니터링 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 혈당 모니터링 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 혈당 모니터링 시장 : 유형별, 2021년-2033년
제5장 세계의 혈당 모니터링 시장 : 컴포넌트별, 2021년-2033년
제6장 세계의 혈당 모니터링 시장 : 최종사용자별, 2021년-2033년
제7장 세계의 혈당 모니터링 시장 : 지역별, 2021년-2033년
제8장 경쟁 구도
제9장 애널리스트의 견해
제10장 참고 문헌 및 조사 방법
LSH 26.06.18Blood Glucose Monitoring Market is estimated to be valued at USD 23.02 Bn in 2026 and is expected to reach USD 46.59 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 23.02 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.60% | 2033 Value Projection: | USD 46.59 Bn |
Blood glucose monitoring is crucial for managing diabetes as it helps patients monitor their blood sugar levels and take corrective measures on a regular basis. Easy availability and affordability of self-monitoring devices along with growing awareness about diabetes care have been driving the greater adoption of blood glucose monitoring solutions globally. In addition, technological advancements leading to the development of innovative monitoring devices with enhanced features for accuracy, convenience, and connectivity are expected to further propel the market growth in the coming years.
Market Dynamics
The global blood glucose monitoring market has been witnessing steady growth attributed to rising diabetic population worldwide coupled with growing focus on diabetes management. Various factors, such as increasing prevalence of obesity and sedentary lifestyles, are contributing to the diabetes burden globally, which, in turn, is driving the adoption of blood glucose monitoring devices. Additionally, the development of user-friendly and affordable monitoring solutions along with favorable reimbursement policies in developed regions are encouraging the greater uptake of self-monitoring devices. However, high costs associated with advanced blood glucose monitors remains a key challenge, especially in developing countries. Moreover, vulnerabilities to cyber threats and data breaches could hamper the transition towards connected monitoring devices. Nonetheless, ongoing technological upgrades including the development of minimally invasive continuous glucose monitoring systems presents bright prospects for market players.
Key Features of the Study
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global blood glucose monitoring market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study Medtronic, ACON Laboratories, Inc., Senseonics, Inc., Medisana AG, Bionime Corporation, AgaMatrix Inc., ARKRAY, Inc., Rossmax International Ltd., Dexcom, Inc., Nipro Group, B. Braun SE, Nova Biomedical, LifeScan IP Holdings, LLC, Ascensia Diabetes Care Holdings AG, Nemaura, Terumo Corporation, and Hoffmann-La Roche Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global blood glucose monitoring market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood glucose monitoring market.
Market Segmentation
- Type Insights (Revenue, USD Bn, 2021 - 2033)
- Self-monitoring blood glucose devices
- Continuous glucose monitoring devices
- Flash glucose monitoring devices
- Component Insights (Revenue, USD Bn, 2021 - 2033)
- Glucometer devices
- Test strips
- Lancets
- Sensors
- Others
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Homecare Settings
- Ambulatory Care Settings
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Medtronic
- ACON Laboratories, Inc.
- Senseonics, Inc.
- Medisana AG
- Bionime Corporation
- AgaMatrix Inc.
- ARKRAY, Inc.
- Rossmax International Ltd.
- Dexcom, Inc.
- Nipro Group
- B. Braun SE
- Nova Biomedical
- LifeScan IP Holdings, LLC
- Ascensia Diabetes Care Holdings AG
- Nemaura
- Terumo Corporation
- F. Hoffmann-La Roche Ltd
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Component
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Regulatory Scenario
- Technological Advancements
- Manufacturer Revenue
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Blood Glucose Monitoring Market, By Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Self-monitoring blood glucose devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Continuous glucose monitoring devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Flash glucose monitoring devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Blood Glucose Monitoring Market, By Component, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Glucometer devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Test strips
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Lancets
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Sensors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Blood Glucose Monitoring Market, By End User, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Homecare Settings
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ambulatory Care Settings
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Blood Glucose Monitoring Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Medtronic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ACON Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Senseonics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medisana AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bionime Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AgaMatrix Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ARKRAY, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Rossmax International Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Dexcom, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Nipro Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- B. Braun SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Nova Biomedical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- LifeScan IP Holdings, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ascensia Diabetes Care Holdings AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Nemaura
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medtronic
9. Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
